{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T20:17:58Z","timestamp":1782332278194,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,3,1]],"date-time":"2005-03-01T00:00:00Z","timestamp":1109635200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":6296,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2005,3]]},"DOI":"10.1016\/j.fertnstert.2004.11.002","type":"journal-article","created":{"date-parts":[[2005,3,5]],"date-time":"2005-03-05T07:11:39Z","timestamp":1110006699000},"page":"684-690","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"title":["Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin"],"prefix":"10.1016","volume":"83","author":[{"given":"Luis S.","family":"Noble","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H.","family":"Kutteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette","family":"Lashey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney D.","family":"Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan","family":"Herrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2004.11.002_bib1","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1001\/jama.1997.03540430061034","article-title":"Antiphospholipid antibody","volume":"277","author":"Lockshin","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib2","first-page":"135","article-title":"Recurrent pregnancy loss with antiphospholipid antibody: a systematic review of therapeutic trials","volume":"99","author":"Empson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib3","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1016\/S0002-9378(96)70610-5","article-title":"Antiphospholipid antibody-associated recurrent pregnancy loss: treatment with heparin and low-dose aspirin is superior to low-dose aspirin alone","volume":"174","author":"Kutteh","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib4","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1136\/bmj.314.7076.253","article-title":"Randomized, controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)","volume":"314","author":"Rai","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib5","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0049-3848(93)90176-O","article-title":"Inhibition of heparin\/antithrombin III cofactor activity by anticardiolipin antibodies: a mechanism for thrombosis","volume":"71","author":"Chamley","year":"1993","journal-title":"Thromb Res"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1093\/humrep\/17.4.1067","article-title":"Defective endovascular trophoblast invasion in primary antiphospholiplid antibody syndrome-associated early pregnancy failure","volume":"17","author":"Sebire","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/01.AOG.0000128902.84876.d4","article-title":"Effects of low-molecular weight and unfractionated heparin on trophoblast function","volume":"104","author":"Quenby","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib8","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1592\/phco.19.13.1013.31588","article-title":"Low-molecular-weight heparins during pregnancy","volume":"19","author":"Ensom","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib9","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0002-9378(93)90100-W","article-title":"Prevention of fetal loss in experimental antiphospholipid syndrome by low-molecular-weight heparin","volume":"169","author":"Inbar","year":"1993","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2141.1988.00491.x-i1","article-title":"Annotation: antiphospholipid antibodies","volume":"74","author":"Harris","year":"1990","journal-title":"Br J Haematol"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib12","first-page":"811","article-title":"Multiples of the median: alternate methods for reporting antiphospholipid antibodies in women with recurrent pregnancy loss","volume":"84","author":"Kutteh","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib13","first-page":"455","article-title":"Effects of unfractionated and low molecular weight heparin on antiphospholipid antibody binding in vitro","volume":"101","author":"Franklin","year":"2003","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib14","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/0029-7844(95)00452-1","article-title":"Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies","volume":"87","author":"Dulitzki","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib15","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/S0002-9378(97)70403-4","article-title":"Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-nine pregnancies in sixty-one women at high risk","volume":"176","author":"Nelson-Piercy","year":"1997","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib16","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1055\/s-0037-1613894","article-title":"Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin","volume":"83","author":"Brenner","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib17","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1097\/00006250-200212000-00032","article-title":"Antiphospholipid syndrome in pregnancy: a randomized control trial of treatment","volume":"100","author":"Farquharson","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2004.11.002_bib18","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1191\/096120301678415999","article-title":"International classification criteria for antiphospholipid syndrome: synopsis of a post-conference workshop held at the Ninth International (Tours) aPL Symposium","volume":"10","author":"Wilson","year":"2001","journal-title":"Lupus"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028204029838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028204029838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:05:58Z","timestamp":1758006358000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028204029838"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["S0015028204029838"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2004.11.002","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2005,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiphospholipid antibodies associated with recurrent pregnancy loss: Prospective, multicenter, controlled pilot study comparing treatment with low-molecular-weight heparin versus unfractionated heparin","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2004.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}